Procter & Gamble Health Ltd
PGHLProcter & Gamble Health Ltd
PGHLPrice Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
40.73 | 11.61 | 1.17% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
46.01 | 6.09 | 0.55% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Procter & Gamble Health Limited, formerly Merck Limited, is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Zydus Lifesciences Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 962.81 | 1,016.97 | 772.07 | 1,616.92 | — | 1,424.75 | 1,026.83 | 1,127.60 | 1,248.01 | 1,187.52 | ||||||||||
Raw Materials | 436.87 | 413.32 | 222.95 | 272.83 | — | 444.47 | 310.39 | 344.55 | 358.99 | 865.47 | ||||||||||
Power & Fuel Cost | 15.14 | 14.96 | 11.68 | 12.23 | 19.09 | 12.97 | 14.70 | 12.88 | ||||||||||||
Employee Cost | 123.17 | 154.23 | 109.88 | 131.27 | 182.93 | 153.66 | 167.56 | 206.17 | ||||||||||||
Selling & Administrative Expenses | 226.39 | 237.59 | 188.49 | 192.98 | 257.28 | 173.99 | 203.91 | 196.86 | ||||||||||||
Operating & Other expenses | 54.49 | 56.89 | 88.16 | 91.53 | 136.68 | 111.70 | 116.01 | 130.04 | ||||||||||||
EBITDA | 106.75 | 139.98 | 150.91 | 916.08 | — | 384.30 | 264.12 | 280.87 | 343.07 | 322.05 | ||||||||||
Depreciation/Amortization | 23.42 | 24.81 | 19.12 | 21.12 | — | 29.45 | 30.04 | 27.08 | 28.10 | 26.74 | ||||||||||
PBIT | 83.33 | 115.17 | 131.79 | 894.96 | — | 354.85 | 234.08 | 253.79 | 314.97 | 295.31 | ||||||||||
Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.80 | 0.42 | 0.77 | 0.69 | ||||||||||
PBT | 83.33 | 115.17 | 131.79 | 894.96 | — | 354.85 | 233.28 | 253.37 | 314.20 | 294.62 | ||||||||||
Taxes & Other Items | 29.77 | 36.04 | 37.88 | 56.24 | — | 100.77 | 56.48 | 60.85 | 84.73 | 80.60 | ||||||||||
Net Income | 53.56 | 79.13 | 93.91 | 838.72 | — | 254.08 | 176.80 | 192.52 | 229.47 | 214.02 | ||||||||||
EPS | 32.27 | 47.67 | 56.57 | 505.27 | — | 153.07 | 106.51 | 115.98 | 138.24 | 128.93 | ||||||||||
DPS | 7.50 | 11.00 | 15.00 | 440.00 | — | 230.00 | 130.00 | 52.50 | 61.50 | 250.00 | ||||||||||
Payout ratio | 0.23 | 0.23 | 0.27 | 0.87 | — | 1.50 | 1.22 | 0.45 | 0.44 | 1.94 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Procter & Gamble Health Ltd | 37.99 | 11.61 | 1.17% |
Sun Pharmaceutical Industries Ltd | 41.74 | 5.96 | 0.81% |
Zydus Lifesciences Ltd | 31.44 | 5.49 | 0.25% |
Cipla Ltd | 29.39 | 5.11 | 0.87% |
Price Comparison
Compare PGHL with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Procter & Gamble Health Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Nippon India Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 3.4973% | Percentage of the fund’s portfolio invested in the stock 0.59% | Change in the portfolio weight of the stock over the last 3 months -0.09% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 80/230 (-6) |
ICICI Prudential Smallcap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.8467% | Percentage of the fund’s portfolio invested in the stock 1.91% | Change in the portfolio weight of the stock over the last 3 months -0.10% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 61/105 (-3) |
UTI AMC LTD # UTI MF-UTI MNC FUND DIRECT PLAN GROWTH PLAN GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.3695% | Percentage of the fund’s portfolio invested in the stock 3.85% | Change in the portfolio weight of the stock over the last 3 months -0.15% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 6/52 (+1) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateFeb 14, 2024
Dividend/Share
₹50.00
Ex DateEx Date
Feb 14, 2024
Cash Dividend
Ex DateEx DateFeb 14, 2024
Dividend/Share
₹150.00
Ex DateEx Date
Feb 14, 2024
Cash Dividend
Ex DateEx DateNov 23, 2023
Dividend/Share
₹50.00
Ex DateEx Date
Nov 23, 2023
Cash Dividend
Ex DateEx DateFeb 13, 2023
Dividend/Share
₹45.00
Ex DateEx Date
Feb 13, 2023
Cash Dividend
Ex DateEx DateNov 15, 2022
Dividend/Share
₹11.50
Ex DateEx Date
Nov 15, 2022
Procter & Gamble Health share price falls 5% on weak Q4 results
Procter & Gamble Health appoints Lokesh Chandak as CFO
Trade Spotlight | Your blueprint for Procter & Gamble Health, M&M Financial Services, Zydus Lifesciences today
Procter & Gamble Health shares surge 15% today amid heavy volumes
Volumes jump at Procter & Gamble Health Ltd counter
Procter & Gamble Health shares spike 13% on 71% surge in profit
Vodafone Idea Ltd leads gainers in ‘A’ group
Volumes spurt at Procter & Gamble Health Ltd counter
Procter & Gamble Health soars after strong December quarter performance
Pharma stock declares ₹45 interim dividend, posts 71% net profit growth in Q3
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant